Hoth Therapeutics Announces Participation at Upcoming Investor Conferences in September
NEW YORK, Aug. 28, 2020 /PRNewswire/ --Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Chief Executive Officer, Robb Knie, is scheduled to present at the following investor conferences in September:
The LD 500 Virtual Investor Conference
H.C. Wainwright & Co. 22nd Annual Global Investment Conference 2020
Sidoti & Company 2020 Fall Virtual Investor Conference
Management will be available for 1x1 meetings with investors throughout each event. Please contact your conference representative to schedule a meeting. To stay up to date on upcoming events please check our calendar regularly: https://ir.hoththerapeutics.com/events/category/events/
About Hoth Therapeutics, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/hoth-therapeutics-announces-participation-at-upcoming-investor-conferences-in-september-301120459.html
SOURCE Hoth Therapeutics, Inc.
Company Codes: NASDAQ-NMS:HOTH